Healthcare

Joint Commission International Honors Healthcare Organizations and National Health Authorities with Inaugural Global Patient Safety Awards

OAK BROOK TERRACE, Ill., Sept. 30, 2026, 09:00 GMT-04

Joint-Commission-Inte

Read full article →

Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China

BEIJING, Sept. 30, 2026, 08:00 GMT-04

Zhendong-Pharma

Read full article →

Latvian Companies and Researchers Sign Defense Technology and Genomics Agreements as LIAA US Trade Mission Concludes

RIGA, Latvia, Sept. 30, 2026, 08:00 GMT-04

Investment-and-Develo

Read full article →

Sinocare Showcases Integrated Chronic Disease Management Solutions at EASD 2026

MILAN, Sept. 30, 2026, 06:10 GMT-04

Sinocare

Read full article →

Newronika Announces First Participant Implanted in ADVENT Pivotal Study

MILAN, Sept. 30, 2026, 05:01 GMT-04

Newronika-SpA

Read full article →

Leads To Development Joins Clarenta Group, Strengthening Early-Stage Drug Development Expertise

LONDON, Sept. 30, 2026, 04:00 GMT-04

Clarenta-Group

Read full article →

Change in number of shares and votes in Sobi

STOCKHOLM, Sept. 30, 2026, 02:15 GMT-04

Swedish-Orphan-Biovit

Read full article →

Roche launches newborn screening test for three severe genetic conditions

BERLIN, Sept. 30, 2026, 01:00 GMT-04

Roche-LightMix-test

Read full article →

ASICS Issues World's First Conservation Warning for Movement as New Research Reveals We're Moving Less

LONDON, Sept. 30, 2026, 00:01 GMT-04

ASICS

Read full article →

ASICS Warns Australia's Movement Levels Will Push Half the Population Into 'Endangered' or 'At Risk' Territory by 2035

SYDNEY, Sept. 30, 2026, 22:00 GMT-04

ASICS

Read full article →

Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility

MUMBAI, India, Sept. 29, 2026, 15:28 GMT-04

Piramal-Pharma

Read full article →

92% of Surveyed TranquilHearts Alumni Report Improved Quality of Life as Center Highlights Skills-Based Recovery Programming

MERIDA, Mexico, Sept. 29, 2026, 15:18 GMT-04

TranquilHearts-Privat

Read full article →

Retinitis Pigmentosa Market Outlook to Strengthen During the Forecast Period (2026-2036) with Growing Focus on Disease-Modifying Therapies | DelveInsight

LAS VEGAS, Sept. 29, 2026, 10:31 GMT-04

DelveInsight-Business

Read full article →

Patient Handling Equipment Market worth $17.29 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 29, 2026, 10:30 GMT-04

MarketsandMarkets

Read full article →

Airway Therapeutics Awarded $1.9 Million NIH Grant to Advance Phase 2b/3 Study of Zelpultide Alfa for Prevention of Bronchopulmonary Dysplasia

ATLANTA, Sept. 29, 2026, 09:00 GMT-04

Airway-Therapeutics

Read full article →

The Bulat Utemuratov Foundation and GAAC to Establish a Regional Autism Hub for Central Asia and the South Caucasus

NEW YORK, Sept. 29, 2026, 09:00 GMT-04

The-Bulat-Utemuratov

Read full article →

Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board

CAMBRIDGE, England, Sept. 29, 2026, 08:03 GMT-04

Isomab

Read full article →

Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses

NEW YORK, Sept. 29, 2026, 08:00 GMT-04

Elsevier-Limited

Read full article →

Novo's Ozempic® (semaglutide) 2 mg associated with lower risk of major adverse cardiovascular events (death, heart attack, and stroke) in adults with type 2 diabetes compared to switching to Mounjaro® (tirzepatide), in real-world analysis at EASD

PLAINSBORO, N.J. and BAGSVÆRD, Denmark, Sept. 29, 2026, 06:00 GMT-04

Novo-Nordisk

Read full article →

New Global Aesthetics Report: Eyelid Surgery, Liposuction, and Breast Augmentation Rank as Top Surgical Procedures

LEBANON, N.H., Sept. 29, 2026, 04:12 GMT-04

ISAPS-new-report

Read full article →